Canntab Therapeutics Limited announced earnings results for the full year ended May 31, 2021. For the full year, the company announced operating loss was CAD 3.782 million compared to CAD 2.607 million a year ago. Net loss was CAD 4.419 million compared to CAD 2.607 million a year ago. Basic loss per share from continuing operations was CAD 0.13 compared to CAD 0.1 a year ago.